BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Stem cell
,
Pharmacogenetics
,
Rosiglitazone
,
rs3825942
,
GATA1
,
Apoptosis
,
Ischemia
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Equilibrative nucleoside transporter 1
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Prostate gland
Mammary gland
Adipose tissue subcutaneous
Endometrium
Globus pallidum external
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Tobacco use and exposure (clinical finding)
Musculoskeletal fibromatosis
Septicemia due to Klebsiella
Stricture of artery
Infection due to Pseudomonas
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
kavain
Pilocarpine
Quipazine
Isoflurophate
Gentian Violet
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Mir129
INTS8
PLPP1
REST
ALAS1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Mouse Phenotypes - Substance-related disorders
Transcriptomic effects of the shear stress on cultured osteoblast-like MC3T3 cells
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Acute promyelocytic leukemia HL60 cells treated with ligand perturbagens
L1000 CMAP Osteosarcoma U-2 OS cells with gene overexpression perturbations
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Equilibrative nucleoside transporter 1
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic Cancer
A Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancrea…
Safety and Pharmacokinetic Profiles of Two Formulations of CO-1.01 in Patients With Advanced Solid T…
Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas Cancer
Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pan…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ